Comparative clinical features and immune responses after extended thymectomy for myasthenia gravis in patients with atrophic versus hyperplastic thymus.

[1]  M. Yamakawa,et al.  Expression of BAFF‐R and TACI in reactive lymphoid tissues and B‐cell lymphomas , 2009, Histopathology.

[2]  Chuan-zhen Lu,et al.  Decrease of CD4(+)CD25(high)Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis. , 2008, Clinical immunology.

[3]  G. Pearse.  Histopathology of the Thymus , 2006, Toxicologic pathology.

[4]  C. Buckley,et al.  Transsternal thymectomy for myasthenia gravis: surgical outcome. , 2006, The Annals of thoracic surgery.

[5]  D. Allred,et al.  Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study , 2004, Modern Pathology.

[6]  S. Paiboonpol,et al.  Outcome after transsternal radical thymectomy for myasthenia gravis: 14-year review at Ratchaburi Hospital. , 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[7]  M. Zielinski,et al.  Comparison of late results of basic transsternal and extended transsternal thymectomies in the treatment of myasthenia gravis. , 2004, The Annals of thoracic surgery.

[8]  H. Kaminski,et al.  Pathophysiology of myasthenia gravis. , 2004, Seminars in neurology.

[9]  E. Dikmen,et al.  Predictors of clinical outcome following extended thymectomy in myasthenia gravis. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  Xiaoli Li,et al.  The physiologic role of CD19 cytoplasmic tyrosines. , 2002, Immunity.

[11]  A. Vincent,et al.  Unravelling the pathogenesis of myasthenia gravis , 2002, Nature Reviews Immunology.

[12]  J. Miller,et al.  Predictors of outcome in thymectomy for myasthenia gravis. , 2001, The Annals of thoracic surgery.

[13]  S. Pierce,et al.  The Role of the CD19/CD21 Complex in B Cell Processing and Presentation of Complement-Tagged Antigens , 2001, The Journal of Immunology.

[14]  J. Oger,et al.  In myasthenia gravis cells from atrophic thymus secrete acetylcholine receptor antibodies , 2001, Neurology.

[15]  Y. Obata,et al.  The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent. , 2000, International immunology.

[16]  G. Gronseth,et al.  Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) , 2000, Neurology.

[17]  R. Barohn,et al.  Myasthenia gravis , 2000, Neurology.

[18]  T. Mineo,et al.  Thoracoscopic thymectomy in autoimmune myasthesia: results of left-sided approach. , 2000, The Annals of thoracic surgery.

[19]  B. Haynes,et al.  Analysis of the human thymic perivascular space during aging. , 1999, The Journal of clinical investigation.

[20]  M. Diener-West,et al.  Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. , 1997, Annals of surgery.

[21]  G. Steinmann,et al.  On a causal mechanism of chronic thymic involution in man , 1994, Mechanisms of Ageing and Development.

[22]  G. Schoefl,et al.  Microvasculature of Normal and Involuted Mouse Thymus , 1989 .

[23]  A. Jaretzki,et al.  "Maximal" thymectomy for myasthenia gravis. Surgical anatomy and operative technique. , 1988, The Journal of thoracic and cardiovascular surgery.

[24]  G. Steinmann.  Changes in the human thymus during aging. , 1986, Current topics in pathology. Ergebnisse der Pathologie.

[25]  J. L. Lilienthal,et al.  THE TREATMENT OF MYASTHENIA GRAVIS BY REMOVAL OF THE THYMUS GLAND: PRELIMINARY REPORT , 1941 .